The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients

Non-alcoholic fatty liver disease (NAFLD) is related to metabolic syndrome via insulin resistance, where preventing disease progression is crucial in the management process. The study included 240 NAFLD patients with type 2 diabetes who were randomly allocated into empagliflozin 25 mg (EMPA group),...

Descripción completa

Detalles Bibliográficos
Autores principales: Elhini, Sahar H., Wahsh, Engy A., Elberry, Ahmed A., El Ameen, Nadia F., Abdelfadil Saedii, Ahmed, Refaie, Shereen Mahmoud, Elsayed, Asmaa A., Rabea, Hoda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786599/
https://www.ncbi.nlm.nih.gov/pubmed/36558967
http://dx.doi.org/10.3390/ph15121516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786599/
https://www.ncbi.nlm.nih.gov/pubmed/36558967
http://dx.doi.org/10.3390/ph15121516

Ejemplares similares